Grégory La Sala

This person is no longer with EPFL

About this result

This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

Related publications (4)

Please note that this is not a complete list of this person’s publications. It includes only semantically relevant works. For a full list, please refer to Infoscience.

About
Privacy
Disclaimer

Grégory La Sala

Targeting the oncogenic signaling of the transcription factor STAT3 with potent and selective monobody inhibitors

Btk SH2-kinase interface is critical for allosteric kinase activation and its targeting inhibits B-cell neoplasms

Selective inhibition of STAT3 signaling using monobodies targeting the coiled-coil and N-terminal domains

Selective inhibition of STAT3 signaling using monobodies targeting the coiled-coil and N-terminal domains

Targeting the oncogenic signaling of the transcription factor STAT3 with potent and selective monobody inhibitors

Btk SH2-kinase interface is critical for allosteric kinase activation and its targeting inhibits B-cell neoplasms